HOXA11 and renal cell carcinoma: Overexpression of HOXA11 has been observed in ovarian cancer (28), bladder cancer (29), renal cell carcinoma (29) and lung cancer (30), while downregulation of HOXA11 has been observed in gastric cancer (31) and glioblastoma (32).